Patents Assigned to Protein Express
-
Publication number: 20160333074Abstract: The present invention relates to a novel polypeptide having specific modifications compared to the natural polypeptide. The said novel polypeptide has improved binding characteristics. The present invention also relates to a method of obtaining the said novel polypeptide and to the use of the said novel polypeptides for the treatment of respiratory disorders.Type: ApplicationFiled: October 16, 2014Publication date: November 17, 2016Applicant: U-PROTEIN EXPRESS B.V.Inventors: Marinus VAN EIJK, Hendrik Peter HAAGSMAN
-
Patent number: 8338122Abstract: The invention is in the field of analytical methods suitable for biochemical applications and provides a method for determining the amino acid sequence of a peptide. The determination of amino acid sequences of proteins and peptides is useful in the study of biological systems. The invention relates to a method for determining at least part of the amino acid sequence of a protein comprising the steps of cleaving the protein into proteolytic peptides, ionizing the proteolytic peptides to generate peptide precursor ions, dissociating these peptide precursor ions using tandem mass spectrometry in order to obtain peptide fragment ions, followed by determining the amino acid sequence of a selected proteolytic peptide wherein the cleaving step generates at least one proteolytic peptide with an N-terminal lysine residue and wherein the dissociation of the peptide precursor ions is initiated by electron transfer.Type: GrantFiled: January 14, 2009Date of Patent: December 25, 2012Assignee: U-Protein Express B.V.Inventors: Albert John Roeland Heck, Shabaza Mohammed, Bastiaan Van Breukelen, Nadia Taouatas, Madalina Mihaela Drugan
-
Publication number: 20090311290Abstract: The invention is directed to a suppository based vaccine delivery system for immunizing against urogenital and anorectally transmitted infectious disease in humans and animals and a method for treating the same. More particularly, this invention is directed to a suppository based vaccine delivery system for the prophylaxis against or treatment of urogenital or anorectal transmitted infectious diseases, such as from viral or microbial pathogens.Type: ApplicationFiled: August 17, 2009Publication date: December 17, 2009Applicant: Protein Express, Inc.Inventors: Zsolt Istvan Hertelendy, Murray Weiner, Michael Howell, Joseph Thomas
-
Publication number: 20080220477Abstract: This invention relates to: a labeled amino acid that can be introduced into a protein with the aid of a protein synthesis system; a functional protein having functions derived from a label compound; a labeled amino acid comprising an aromatic ring bound to an amino acid side chain and a label compound bound thereto via the aromatic ring; a functional protein to which the labeled amino acid has been introduced; and a novel method for effectively obtaining a labeled amino acid-tRNA complex.Type: ApplicationFiled: April 22, 2008Publication date: September 11, 2008Applicants: PROTEIN EXPRESS CO., LTD., Takahiro HOHSAKAInventors: Takahiro Hohsaka, Masahiko Sisido
-
Patent number: 7385038Abstract: This invention relates to: a labeled amino acid that can be introduced into a protein with the aid of a protein synthesis system; a functional protein having functions derived from a label compound; a labeled amino acid comprising an aromatic ring bound to an amino acid side chain and a label compound bound thereto via the aromatic ring; a functional protein to which the labeled amino acid has been introduced; and a novel method for effectively obtaining a labeled amino acid-tRNA complex.Type: GrantFiled: July 15, 2003Date of Patent: June 10, 2008Assignees: Protein Express Co., Ltd.Inventors: Takahiro Hohsaka, Masahiko Sisido
-
Patent number: 7361637Abstract: There are provided a method for selection of a substance which is capable of controlling activation of prorenin where an adjusting ability of the activation of prorenin by protein-protein interaction in a profragment region of prorenin as indicator is used; a prorenin activation controlling substance having a function of controlling the activation of prorenin based on protein-protein interaction by a profragment region of prorenin; and hypotensor, organ hypertrophy suppressor and arterial thickening suppressor containing the prorenin activation controlling substance as an effective ingredient.Type: GrantFiled: April 1, 2005Date of Patent: April 22, 2008Assignee: Protein Express Co., Ltd.Inventors: Yuichi Ishida, Fumiaki Suzuki, Kazuo Murakami
-
Publication number: 20070082010Abstract: The invention is directed to a suppository based vaccine delivery system for immunizing against urogenital and anorectally transmitted infectious disease in humans and animals and a method for treating the same. More particularly, this invention is directed to a suppository based vaccine delivery system for the prophylaxis against or treatment of urogenital or anorectal transmitted infectious diseases, such as from viral or microbial pathogens.Type: ApplicationFiled: October 12, 2006Publication date: April 12, 2007Applicant: Protein Express, Inc.Inventors: Zsolt Hertelendy, Murray Weiner, Michael Howell, Joseph Thomas
-
Patent number: 6099853Abstract: This invention is directed to a suppository-based vaccine delivery system for immunizing against urogenital infectious disease in humans and a method for treating same. More particularly, this invention is directed to a suppository-based vaccine delivery system for the prophylaxis against urogenital infectious diseases, such as urinary tract infections. The suppository-based vaccine delivery system is comprised of a vaccine comprised of inactivated bacteria which originate from cultures of 8 to 14 uropathogenic bacteria strains of the species: Escherichia coli, Klebsiella pnieumoniae, Proteus mirabilis, Proteus morganii, and Streptococcus faecalis; and polyethylene glycol suppository base; wherein the suppository is adapted to be inserted into a bodily orifice of a human so as to allow the suppository to be in contact with tissue of the bodily orifice to facilitate transfer of suppository material therethrough.Type: GrantFiled: September 4, 1997Date of Patent: August 8, 2000Assignee: Protein ExpressInventors: Zsolt Istvan Hertelendy, Murray Weiner